Cell No. : Cell Name RCB5294 : RMM-C  update : 2023/10/16
Comment			Currently not ready.
Comment from the depositor			Cell line established from a rat spontaneous malignant amelanotic melanoma.
Terms and conditions
Remarks
Order Form
			Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
	Basic information	Expected time	Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
		Depositor	Yamate, Jyoji
		Cellosaurus(Expasy)	CVCL_A6UU
Reference information		Reference	2
		User's Publication	0

Top

Reference

5536  A Bondoc , H M Golbar , M Pervin, C Katou-Ichikawa, M Tanaka, T Izawa, M Kuwamura, J Yamate  Participation of Tumor-Associated Myeloid Cells in Progression of Amelanotic Melanoma (RMM Tumor Line) in F344 Rats, with Particular Reference to MHC Class II- and CD163-Expressing Cells  Cancer Microenviron  2017  10(1-3):9-24  PubMed ID: 28623530   DOI: 10.1007/s12307-017-0193-x

4438  Alexandra Bondoc, Chisa Katou-Ichikawa, Hossain M Golbar, Miyuu Tanaka, Takeshi Izawa, Mitsuru Kuwamura , Jyoji Yamate   Establishment and characterization of a transplantable tumor line (RMM) and cell line (RMM-C) from a malignant amelanotic melanoma in the F344 rat, with particular reference to galectin-3 expression in vivo and in vitro  Histol Histopathol   2016  31(11):1195-207  PubMed ID: 26949998   DOI: 10.14670/HH-11-748

Top

User's Publication